XORTX Therapeutics (XRTX) Current Leases (2022 - 2025)
XORTX Therapeutics' (XRTX) quarterly Current Leases came in at $37287.0 in Q4 2025, down 3.86% YoY from $38785.0 in Q4 2024, and down 3.86% on a QoQ basis from $38785.0 in Q4 2024.
XORTX Therapeutics (XRTX) Current Leases (2022 - 2025) Analysis & Trends
XORTX Therapeutics (XRTX) has 4 years of Current Leases data on file, last reported at $37287.0 in Q4 2025.
- Quarterly Current Leases fell 3.86% year-over-year to $37287.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $37287.0 (down 3.86% YoY) and the FY2025 annual result came in at $37287.0, down 3.86% from the prior year.
- Current Leases retreated to $37287.0 in Q4 2025, from $38785.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $67556.0 in Q2 2022 to a low of $11510.0 in Q4 2023.
- A 4-year average of $43768.9 and a median of $41985.0 in 2023 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2023 — Current Leases plunged 82.55% — and 2024, when it soared 236.97%.
- Tracing XRTX's Current Leases over 4 years: stood at $65947.4 in 2022, then sank by 82.55% to $11510.0 in 2023, then soared by 236.97% to $38785.0 in 2024, then slipped by 3.86% to $37287.0 in 2025.
- The last three Current Leases figures came in at $37287.0 (Q4 2025), $38785.0 (Q4 2024), and $14037.0 (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | XORTX Therapeutics | 2.84 Mn | 2.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 37,287.00 |
| Dec 31, 2024 | 38,785.00 |
| Mar 31, 2024 | 14,037.00 |
| Dec 31, 2023 | 11,510.00 |
| Sep 30, 2023 | 28,512.00 |
| Jun 30, 2023 | 45,185.00 |
| Mar 31, 2023 | 61,536.00 |
| Dec 31, 2022 | 65,947.44 |
| Sep 30, 2022 | 67,333.36 |
| Jun 30, 2022 | 67,556.04 |